Max Kepler Signs with Diamondbacks While Still Serving Suspension for Performance-Enhancing Drugs
Max Kepler remains on the restricted list until June 25, and Arizona says the left-handed bat could help a lineup ranked 23rd in OPS.
- The Arizona Diamondbacks signed outfielder Max Kepler to a one-year deal on Sunday, though Kepler remains on the restricted list serving an 80-game PED suspension until he can report June 25.
- MLB suspended Kepler for 80 games after he tested positive in January for Epitrenbolone, a metabolite of Trenbolone used in bodybuilding products. He will not count against Arizona's 40-man roster until his penalty concludes.
- General manager Mike Hazen noted the lineup needed more power to improve an offense tied for 23rd in MLB team OPS. The Diamondbacks have hit only 58 homers, ranking 26th in the league.
- Regardless of his return, Kepler is ineligible for the 2026 postseason. The 33-year-old outfielder, who played for the Philadelphia Phillies last year, aims to re-establish his value before free agency.
- Once a slugger who hit 36 home runs in 2019, Kepler hopes to find form after a difficult 2025 season. He is using this contract to prepare for free agency next offseason.
39 Articles
39 Articles
Idaho Press
The Herald JournalMax Kepler signs with Diamondbacks while still serving a suspension for a performance-enhancing drug
Outfielder Max Kepler, still serving an 80-game suspension for testing positive for a performance-enhancing drug, agreed to a contract with the Arizona Diamondbacks for a prorated share of the $780,000 minimum and the chance to earn $500,000 in roster bonuses.…
When can Max Kepler play again? Return details explored after PED-suspended slugger signs with Diamondbacks
The Arizona Diamondbacks announced on Sunday that the team had reached an agreement to sign outfielder Max Kepler, who had been suspended by the MLB earlier in the offseason due to testing positive fo
Rockdale Citizen & Newton Citizen
Reports: Diamondbacks sign suspended OF Max Kepler
Max Kepler has 18 days remaining until his suspension for performance-enhancing drug usage is over. But when the ban is over, the outfielder now knows where he'll be headed.
Max Kepler signs with Diamondbacks while still serving a suspension for performance-enhancing drugs
Outfielder Max Kepler, still serving an 80-game suspension for testing positive for performance-enhancing drugs, agreed to a contract with the Arizona Diamondbacks for a prorated share of the $780,000 minimum and the chance to earn $500,000 in roster bonuses.
Coverage Details
Bias Distribution
- 52% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
